BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28264803)

  • 1. Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study.
    Nembhard WN; Tang X; Hu Z; MacLeod S; Stowe Z; Webber D;
    BMJ; 2017 Mar; 356():j832. PubMed ID: 28264803
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
    Alwan S; Reefhuis J; Rasmussen SA; Olney RS; Friedman JM;
    N Engl J Med; 2007 Jun; 356(26):2684-92. PubMed ID: 17596602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conotruncal heart defects and common variants in maternal and fetal genes in folate, homocysteine, and transsulfuration pathways.
    Hobbs CA; Cleves MA; Macleod SL; Erickson SW; Tang X; Li J; Li M; Nick T; Malik S;
    Birth Defects Res A Clin Mol Teratol; 2014 Feb; 100(2):116-26. PubMed ID: 24535845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A parent-of-origin analysis of paternal genetic variants and increased risk of conotruncal heart defects.
    Nembhard WN; Tang X; Li J; MacLeod SL; Levy J; Schaefer GB; Hobbs CA;
    Am J Med Genet A; 2018 Mar; 176(3):609-617. PubMed ID: 29399948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paternal genetic variants and risk of obstructive heart defects: A parent-of-origin approach.
    Patel J; Bircan E; Tang X; Orloff M; Hobbs CA; Browne ML; Botto LD; Finnell RH; Jenkins MM; Olshan A; Romitti PA; Shaw GM; Werler MM; Li J; Nembhard WN;
    PLoS Genet; 2021 Mar; 17(3):e1009413. PubMed ID: 33684136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort Studies.
    Wang S; Yang L; Wang L; Gao L; Xu B; Xiong Y
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25991012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.
    Reefhuis J; Devine O; Friedman JM; Louik C; Honein MA;
    BMJ; 2015 Jul; 351():h3190. PubMed ID: 26156519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
    Louik C; Lin AE; Werler MM; Hernández-Díaz S; Mitchell AA
    N Engl J Med; 2007 Jun; 356(26):2675-83. PubMed ID: 17596601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common 894G>T single nucleotide polymorphism in the gene coding for endothelial nitric oxide synthase (eNOS) and risk of congenital heart defects.
    van Beynum IM; Mooij C; Kapusta L; Heil S; den Heijer M; Blom HJ
    Clin Chem Lab Med; 2008; 46(10):1369-75. PubMed ID: 18844489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of maternal folate use and reduced folate carrier gene polymorphisms with the risk of congenital heart disease in offspring.
    Qin J; Li J; Li F; Sun M; Wang T; Diao J; Zhang S; Luo L; Li Y; Chen L; Huang P; Zhu P
    Eur J Pediatr; 2021 Oct; 180(10):3181-3190. PubMed ID: 33913025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation.
    van Beynum IM; Kapusta L; den Heijer M; Vermeulen SH; Kouwenberg M; Daniëls O; Blom HJ
    Eur Heart J; 2006 Apr; 27(8):981-7. PubMed ID: 16524890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
    Källén BA; Otterblad Olausson P
    Birth Defects Res A Clin Mol Teratol; 2007 Apr; 79(4):301-8. PubMed ID: 17216624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy--an epidemiological study using validated EUROCAT data.
    Knudsen TM; Hansen AV; Garne E; Andersen AM
    BMC Pregnancy Childbirth; 2014 Sep; 14():333. PubMed ID: 25258023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors and congenital heart anomalies: comparative cohort studies of women treated before and during pregnancy and their children.
    Petersen I; Evans SJ; Gilbert R; Marston L; Nazareth I
    J Clin Psychiatry; 2016 Jan; 77(1):e36-42. PubMed ID: 26845280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
    Gao SY; Wu QJ; Sun C; Zhang TN; Shen ZQ; Liu CX; Gong TT; Xu X; Ji C; Huang DH; Chang Q; Zhao YH
    BMC Med; 2018 Nov; 16(1):205. PubMed ID: 30415641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes.
    Shaw GM; Iovannisci DM; Yang W; Finnell RH; Carmichael SL; Cheng S; Lammer EJ
    Am J Med Genet A; 2005 Sep; 138(1):21-6. PubMed ID: 16100725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of periconceptional folate supplements and
    Song X; Huang P; Wang T; Zhang S; Chen L; Qin J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):52-62. PubMed ID: 35545363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between maternal genotypes and metabolites implicated in congenital heart defects.
    Chowdhury S; Hobbs CA; MacLeod SL; Cleves MA; Melnyk S; James SJ; Hu P; Erickson SW
    Mol Genet Metab; 2012 Nov; 107(3):596-604. PubMed ID: 23059056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.
    Wemakor A; Casson K; Garne E; Bakker M; Addor MC; Arriola L; Gatt M; Khoshnood B; Klungsoyr K; Nelen V; O'Mahoney M; Pierini A; Rissmann A; Tucker D; Boyle B; de Jong-van den Berg L; Dolk H
    Eur J Epidemiol; 2015 Nov; 30(11):1187-98. PubMed ID: 26148560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic association study detects haplotypes associated with obstructive heart defects.
    Li M; Cleves MA; Mallick H; Erickson SW; Tang X; Nick TG; Macleod SL; Hobbs CA;
    Hum Genet; 2014 Sep; 133(9):1127-38. PubMed ID: 24894164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.